Schedule 13G ownership disclosure

Olema Pharmaceuticals Inc

Security class unavailable · CUSIP: 68062P106

Event date: 2022-12-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,025,234
Percent of class
5.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001085146-23-001477
Form type
SC 13G/A
Filer
Kynam Capital Management, LP
CIK
CIK 1907884
Filed
Mar 22, 2023
Reporting period
Dec 30, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub